Patients should be aware of two serious conditions that can present with abdominal pain: pancreatitis and gallbladder disease
Yes, 15 mg once weekly is the maximum dosage for tirzepatide
It simultaneously targets three core human metabolic receptors, forming a closed-loop metabolic regulation system of "reducing intake, boosting metabolism, and improving insulin resistance" this is the core reason why its efficacy far exceeds semaglutide
These functions of GLP-1R in the CM model is mediated by its downstream PI3K/Akt pathway (Fig
In the U.S., CMS guidance from March 2024 allows Medicare Part D coverage of AOMs with medically accepted indications, such as diabetes or reducing the risk of major adverse cardiovascular events in patients with established cardiovascular disease
From a mechanistic standpoint, both compounds activate the same GLP-1 and GIP receptors, which means concurrent administration would likely result in receptor saturation at those pathways without proportional additive benefit